Delivery Order SPE2DB22D1202-SPE2DB24FUGR0
Award Date
11/9/23
Potential Completion Date
11/13/23
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $44,039.19 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of 4,566,088 units of the CONTRAVE ER 8-90 MG TABLET 120S medication. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, that enables the government to efficiently procure a wide range of pharmaceutical and medical supplies to support...
The Defense Logistics Agency (DLA) awarded a $4,732.93 firm-fixed-price delivery order to AmerisourceBergen Drug Corp to provide 120 tablets of the drug CONTRAVE ER 8-90 MG TABLET. This delivery order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide CONTRAVE ER 8-90 MG TABLET 120S. The delivery order, valued at $8,645.94, has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $25,290.45 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide CONTRAVE ER 8-90 MG TABLET 120S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 with DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,557.67 firm fixed-price delivery order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a $3,606.02 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
The U.S. government awarded a $11,931.44 fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency Troop Support Medical. This award is under AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a comprehensive vehicle for supplying pharmaceuticals and medical supplies to support military healthcare programs globally. The...
The U.S. Defense Logistics Agency (DLA) awarded a $5,563.06 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 120 tablets of the medication CONTRAVE ER 8-90 MG. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 120 tablets of the pharmaceutical product CONTRAVE ER 8-90 MG. The contract has a potential value of $2,040.68 and a completion date of February 15, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,727.25 firm-fixed-price delivery order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...